If you're at low risk for heart problems and take a statin to lower your 'bad' cholesterol by a small amount, you're about 11% less likely to have a heart attack or stroke over the next five years — out of 1000 people like you, roughly 11 fewer will have a major heart or blood vessel problem.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
probability
Can suggest probability/likelihood
Assessment Explanation
This claim is based on meta-analyses of randomized controlled trials (e.g., Cholesterol Treatment Trialists’ Collaboration) that consistently show a linear relationship between LDL reduction and vascular event risk reduction, even in low-risk populations. The 21% relative risk reduction per 1.0 mmol/L LDL lowering is a well-replicated finding. The absolute benefit (11/1000) is derived from baseline risk estimates and is mathematically consistent with the relative risk reduction. The claim avoids overstatement by specifying the population and time frame, and uses precise quantitative language. However, 'reduces' implies causality, which is justified by RCT evidence, but 'probability' is more precise than definitive language because individual outcomes vary.
More Accurate Statement
“In individuals with a 5-year vascular risk below 10% and no prior vascular disease, diabetes, or chronic kidney disease, statin therapy that lowers LDL cholesterol by 1.0 mmol/L is associated with a probable 21% relative reduction in major vascular events over 5 years, corresponding to approximately 11 fewer events per 1000 people.”
Context Details
Domain
medicine
Population
human
Subject
Individuals with a 5-year risk of vascular disease below 10%, without prior vascular disease, diabetes, or chronic kidney disease
Action
reduces
Target
the risk of major vascular events by 21% relative and 11 fewer events per 1000 people over 5 years
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
This big study looked at thousands of people with low risk of heart problems and found that taking statins to lower LDL cholesterol by 1 point reduced their chance of heart attacks or strokes by about 11 out of every 1000 people over 5 years — exactly what the claim says.